Rafferty Asset Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.39M | Buy |
136,619
+4,273
| +3% | +$111K | 0.01% | 495 |
|
|
2025
Q4 | $3.36M | Buy |
132,346
+30,483
| +30% | +$680K | 0.01% | 534 |
|
|
2025
Q3 | $1.64M | Sell |
101,863
-4,607
| -4% | -$74.6K | 0.01% | 691 |
|
|
2025
Q2 | $1.7M | Sell |
106,470
-32,367
| -23% | -$489K | 0.01% | 642 |
|
|
2025
Q1 | $2.37M | Buy |
138,837
+22,213
| +19% | +$465K | 0.01% | 530 |
|
|
2024
Q4 | $2.89M | Sell |
116,624
-35,723
| -23% | -$1.01M | 0.01% | 537 |
|
|
2024
Q3 | $4.34M | Buy |
152,347
+11,649
| +8% | +$344K | 0.01% | 456 |
|
|
2024
Q2 | $3.71M | Sell |
140,698
-148,687
| -51% | -$4.23M | 0.01% | 481 |
|
|
2024
Q1 | $9.35M | Buy |
289,385
+60,298
| +26% | +$2.2M | 0.03% | 287 |
|
|
2023
Q4 | $9.65M | Sell |
229,087
-67,745
| -23% | -$2.49M | 0.04% | 292 |
|
|
2023
Q3 | $11.4M | Buy |
296,832
+45,211
| +18% | +$1.02M | 0.07% | 192 |
|
|
2023
Q2 | $4.77M | Sell |
251,621
-76,295
| -23% | -$1.42M | 0.03% | 423 |
|
|
2023
Q1 | $5.09M | Buy |
327,916
+97,343
| +42% | +$1.69M | 0.03% | 380 |
|
|
2022
Q4 | $4.09M | Buy |
+230,573
| New | +$2.9M | 0.03% | 418 |
|
|
2022
Q1 | – | Sell |
-189,926
| Closed | -$1.62M | – | 1272 |
|
|
2021
Q4 | $1.62M | Buy |
189,926
+610
| +0.3% | +$5.04K | 0.01% | 738 |
|
|
2021
Q3 | $1.65M | Sell |
189,316
-17,873
| -9% | -$161K | 0.01% | 686 |
|
|
2021
Q2 | $2.19M | Buy |
207,189
+11,091
| +6% | +$155K | 0.01% | 661 |
|
|
2021
Q1 | $3.15M | Buy |
196,098
+179,130
| +1,056% | +$4.72M | 0.02% | 457 |
|
|
2020
Q4 | $784K | Sell |
16,968
-4,567
| -21% | -$211K | 0.01% | 575 |
|
|
2020
Q3 | $758K | Buy |
+21,535
| New | +$648K | 0.01% | 619 |
|
Other funds holding IMVT
DTC
BBA
TCM
VPM
VCM
